StockData
IQVIA Holdings Inc. logo

IQVIA Holdings Inc. (IQV) stock

IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3014% above fair value
$257.60−7.13 (-2.69%)

Close on Nov 17, 2026Market cap $42.45BP/E 31.3Yield –

Iqvia r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2015 it was $3.34M, down 42.4% from the year before. The highest annual figure on record is $10.43M in fiscal 2012.

Annual r&d expenses

PeriodPeriod endValueChange
FY2015Dec 31, 2015$3.34M-42.4%
FY2014Dec 31, 2014$5.79M+16.9%
FY2013Dec 31, 2013$4.96M-52.5%
FY2012Dec 31, 2012$10.43M+4.4%
FY2011Dec 31, 2011$9.99M–

More Iqvia figures

See a number that looks wrong?